These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34350058)

  • 1. Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.
    Kaddoura R; Elmoheen A; Badawy E; Eltawagny MF; Seif MA; Bashir K; Salam AM
    J Drug Assess; 2021; 10(1):68-85. PubMed ID: 34350058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Karami M; Hemradj VV; Ouweneel DM; den Uil CA; Limpens J; Otterspoor LC; Vlaar AP; Lagrand WK; Henriques JPS
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32629772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
    Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
    Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
    Shabana A; Dholoo F; Banerjee P
    Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database.
    Sasmita BR; Wang C; Xie S
    Front Cardiovasc Med; 2023; 10():1300839. PubMed ID: 38094120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
    Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
    Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome.
    Kaddoura R; Elbdri S
    Rev Cardiovasc Med; 2021 Sep; 22(3):691-715. PubMed ID: 34565070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock.
    Bloom JE; Chan W; Kaye DM; Stub D
    J Am Heart Assoc; 2023 Aug; 12(15):e029787. PubMed ID: 37489740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
    Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
    J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B; Buzon J; Kimmoun A
    Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock.
    Udesen NLJ; Helgestad OKL; Banke ABS; Frederiksen PH; Josiassen J; Jensen LO; Schmidt H; Edelman ER; Chang BY; Ravn HB; Møller JE
    Crit Care; 2020 Mar; 24(1):95. PubMed ID: 32188462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.
    Jentzer JC; Coons JC; Link CB; Schmidhofer M
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):249-60. PubMed ID: 25432872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
    J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current use of inotropes in circulatory shock.
    Scheeren TWL; Bakker J; Kaufmann T; Annane D; Asfar P; Boerma EC; Cecconi M; Chew MS; Cholley B; Cronhjort M; De Backer D; Dubin A; Dünser MW; Duranteau J; Gordon AC; Hajjar LA; Hamzaoui O; Hernandez G; Kanoore Edul V; Koster G; Landoni G; Leone M; Levy B; Martin C; Mebazaa A; Monnet X; Morelli A; Payen D; Pearse RM; Pinsky MR; Radermacher P; Reuter DA; Sakr Y; Sander M; Saugel B; Singer M; Squara P; Vieillard-Baron A; Vignon P; Vincent JL; van der Horst ICC; Vistisen ST; Teboul JL
    Ann Intensive Care; 2021 Jan; 11(1):21. PubMed ID: 33512597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern drug therapy in cardiovascular intensive care medicine].
    Lemm H; Dietz S; Janusch M; Buerke M
    Internist (Berl); 2015 Jun; 56(6):702, 704-8, 710-2. PubMed ID: 26054838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support.
    Nandkeolyar S; Doctorian T; Fraser G; Ryu R; Fearon C; Tryon D; Kagabo W; Abramov D; Hauschild C; Stoletniy L; Hilliard A; Sakr A
    Clin Med Insights Cardiol; 2021; 15():11795468211049449. PubMed ID: 34720602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.